Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Sensei Biotherapeutics Inc (SNSE)

Sensei Biotherapeutics Inc (SNSE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Sensei Biotherapeutics Inc 1405 RESEARCH BLVD SUITE 125 ROCKVILLE MD 20850 USA

www.senseibio.com Employees: 15 P: 240-243-8000

Sector:

Medical

Description:

Sensei Biotherapeutics Inc. is a clinical-stage immunotherapy company. It is focused on the discovery and development of therapeutics for cancer. The company's product pipeline includes SNS-301, SNS-401 and SNS-VISTA. Sensei Biotherapeutics Inc. is based in BOSTON, Md.

Key Statistics

Overview:

Market Capitalization, $K 37,599
Enterprise Value, $K 27,609
Shares Outstanding, K 1,261
Float, K 969
% Float 76.80%
Short Interest, K 26
Short Float 2.06%
Days to Cover 1.00
Short Volume Ratio 0.42
% of Insider Shareholders 23.20%
% of Institutional Shareholders 10.50%

Financials:

Annual Sales, $ 0 K
Annual Net Income, $ -30,160 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -4,570 K
EBIT, $ -24,650 K
EBITDA, $ -23,330 K

Growth:

1-Year Return 236.43%
3-Year Return 0.00%
5-Year Return -91.21%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -3.62 on 11/14/25
Next Earnings Date 03/27/26 [--]
Earnings Per Share ttm -18.33
EPS Growth vs. Prev Qtr 7.42%
EPS Growth vs. Prev Year 37.59%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-20 on 06/17/25

SNSE Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -76.85%
Return-on-Assets % -64.86%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 1.67
Book Value/Share 18.26
Interest Coverage -334.11
60-Month Beta -0.14
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar